These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22153942)

  • 1. 5-HT₂c receptor selectivity and structure-activity relationship of N-methyl-N-(1-methylpiperidin-4-yl)benzenesulfonamide analogs.
    Jang JW; Baek JS; Choi GD; Park WK; Cho YS; Baek DJ; Pae AN
    Bioorg Med Chem Lett; 2012 Jan; 22(1):347-52. PubMed ID: 22153942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of structural determinants of ligand selectivity in 5-HT₂ receptor subtypes on the basis of protein-ligand interactions.
    Jang JW; Kim MS; Cho YS; Cho AE; Pae AN
    J Mol Graph Model; 2012 Sep; 38():342-53. PubMed ID: 23085173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel structural insights for drug design of selective 5-HT(2C) inverse agonists from a ligand-biased receptor model.
    Renault N; Gohier A; Chavatte P; Farce A
    Eur J Med Chem; 2010 Nov; 45(11):5086-99. PubMed ID: 20880612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.
    Kanagarajadurai K; Malini M; Bhattacharya A; Panicker MM; Sowdhamini R
    Mol Biosyst; 2009 Dec; 5(12):1877-88. PubMed ID: 19763327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
    Ahmed A; Choo H; Cho YS; Park WK; Pae AN
    Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship of 1H-indole-3-carboxylic acid pyridine-3-ylamides: a novel series of 5-HT2C receptor antagonists.
    Park CM; Kim SY; Park WK; Park NS; Seong CM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3844-7. PubMed ID: 18602261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT₂C agonists.
    Conway RJ; Valant C; Christopoulos A; Robertson AD; Capuano B; Crosby IT
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2560-4. PubMed ID: 22381048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
    Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Sulfonamido-3-benzazepines as potent and selective 5-HT2C receptor agonists: hit-to-lead optimization.
    Fish PV; Brown AD; Evrard E; Roberts LR
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1871-5. PubMed ID: 19269173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
    J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position 5.46 of the serotonin 5-HT2A receptor contributes to a species-dependent variation for the 5-HT2C agonist (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: impact on selectivity and toxicological evaluation.
    Miller KJ; Wu GY; Varnes JG; Levesque P; Li J; Li D; Robl JA; Rossi KA; Wacker DA
    Mol Pharmacol; 2009 Dec; 76(6):1211-9. PubMed ID: 19767451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of (piperazin-1-yl-phenyl)-arylsulfonamides: a novel series of atypical antipsychotic agents.
    Park CM; Kim SY; Park WK; Choi JH; Seong CM
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5221-4. PubMed ID: 20655748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
    Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
    Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor.
    Setola V; Dukat M; Glennon RA; Roth BL
    Mol Pharmacol; 2005 Jul; 68(1):20-33. PubMed ID: 15831837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.
    Braden MR; Parrish JC; Naylor JC; Nichols DE
    Mol Pharmacol; 2006 Dec; 70(6):1956-64. PubMed ID: 17000863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal region of the human 5-HT₂C receptor has as a cleavable signal peptide.
    Jahnsen JA; Uhlén S
    Eur J Pharmacol; 2012 Jun; 684(1-3):44-50. PubMed ID: 22497996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist.
    Forbes IT; Dabbs S; Duckworth DM; Jennings AJ; King FD; Lovell PJ; Brown AM; Collin L; Hagan JJ; Middlemiss DN; Riley GJ; Thomas DR; Upton N
    J Med Chem; 1998 Feb; 41(5):655-7. PubMed ID: 9513592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.